Scientists identify MDGA2 as a new genetic cause of severe childhood epilepsy, enabling earlier diagnosis and opening paths for targeted treatments in DEE patients.

Mumbai: Lupin Limited has announced the launch of Topiramate Extended-Release Capsules in the United States after receiving ...

Lupin has launched topiramate extended-release capsules (25 mg, 50 mg, 100 mg, 200 mg) in the US after FDA ANDA approval. The ...

The DGIST Center for Synapse Diversity and Specificity has identified MDGA2 as a novel causative gene for developmental and epileptic encephalopathy (DEE), a rare and intractable neurological disorder ...

Newsweek’s Leonardo Feldman reports that a partial government shutdown has entered day three after President Donald Trump and ...

Professor Jaewon Ko’s research team at DGIST, in collaboration with international researchers, identified that the loss of function of the MDGA2 gene induces severe developmental and epileptic encepha ...

Indoco Remedies has secured final USFDA approval for its generic Lacosamide oral solution, a bioequivalent of Vimpat, enabling the company to market this essential epilepsy treatment in the US from ...

The House rules committee is considering the deal the Senate passed on Friday, separating the Department of Homeland Security and providing just two weeks of funding. This will allow lawmakers to ...

Russia said two crew members of a Russian-flagged oil tanker seized by the United States earlier this month have been ...

Indoco Remedies receives USFDA approval to market generic Lacosamide oral solution for epilepsy treatment. Manufactured in Goa facility.

The announcement came a day after Israeli strikes killed at least 30 Palestinians, according to hospital officials, yet the ...